Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Editorials

First line asciminib in chronic myeloid leukemia: a quest for the “Holy Grail” of tolerability.

Saint-Louis University Hospital
Haematologica Early view Sep 10, 2026 https://doi.org/10.3324/haematol.2026.301753

Abstract

Not available.

Figures & Tables

Article Information

Early view : Editorials
 
DOI
https://doi.org/10.3324/haematol.2026.301753
 
Published
2026-09-10
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
106
PDF Downloads
104
No Data
PlumX
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online